Although ATF3 was reported to decrease the p53 mRNA level in human umbilical vein endothelial cells and human keratinocytes [47, 48], it is worth noting that this contrary effect likely limits to specific cell types as we have never seen such an effect in either primary or cancer cells that we intensively investigated. This evidence concerns the gene ATF3 and cancer.